Monoclonal Antibody and Fusion Protein Biosimilars Across Therapeutic Areas: A Systematic Review of Published Evidence

被引：0
|
作者：
Ira Jacobs
Danielle Petersel
Lesley G. Shane
Chee-Keng Ng
Carol Kirchhoff
Gregory Finch
Sadiq Lula
机构：
[1] Pfizer Inc.,Global Established Pharma Medicines Development Group
[2] Pfizer Inc.,Outcomes and Evidence, Global Health and Value
[3] Pfizer Inc.,Analytical Research and Development, Biotherapeutics Pharmaceutical Sciences
[4] Pfizer Inc.,Global Technology Services, Biotechnology and Aseptic Sciences
[5] Pfizer Inc.,Drug Safety Research and Development
[6] Envision Pharma Group,undefined
来源：
BioDrugs | 2016年 / 30卷
关键词：
Infliximab; Etanercept; Adalimumab; Abciximab; Ranibizumab;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：489 / 523
页数：34
相关论文
共 50 条
  • [1] Monoclonal Antibody and Fusion Protein Biosimilars Across Therapeutic Areas: A Systematic Review of Published Evidence
    Jacobs, Ira
    Petersel, Danielle
    Shane, Lesley G.
    Ng, Chee-Keng
    Kirchhoff, Carol
    Finch, Gregory
    Lula, Sadiq
    BIODRUGS, 2016, 30 (06) : 489 - 523
  • [2] Systematic Review of Evidence for Monoclonal Antibody Biosimilars for the Treatment of Inflammatory Bowel Disease
    Petersel, Danielle
    Cheung, Raymond
    Sewell, K. Lea
    Singh, Ena
    Isakov, Leah
    Jacobs, Ira
    INFLAMMATORY BOWEL DISEASES, 2017, 23 : S30 - S30
  • [3] Biosimilars for the Treatment of Cancer: A Systematic Review of Published Evidence
    Jacobs, Ira
    Ewesuedo, Reginald
    Lula, Sadiq
    Zacharchuk, Charles
    BIODRUGS, 2017, 31 (01) : 1 - 36
  • [4] Biosimilars for the Treatment of Cancer: A Systematic Review of Published Evidence
    Ira Jacobs
    Reginald Ewesuedo
    Sadiq Lula
    Charles Zacharchuk
    BioDrugs, 2017, 31 : 1 - 36
  • [5] Biosimilars for the Treatment of Chronic Inflammatory Diseases: A Systematic Review of Published Evidence
    Jacobs, Ira
    Petersel, Danielle
    Isakov, Leah
    Lula, Sadiq
    Sewell, K. Lea
    BIODRUGS, 2016, 30 (06) : 525 - 570
  • [6] Biosimilars for the Treatment of Chronic Inflammatory Diseases: A Systematic Review of Published Evidence
    Ira Jacobs
    Danielle Petersel
    Leah Isakov
    Sadiq Lula
    K. Lea Sewell
    BioDrugs, 2016, 30 : 525 - 570
  • [7] Systematic review of clinical trials for monoclonal antibody biosimilars in HER2-positive breast cancer
    Jacobs, I.
    Isakov, L.
    Vana, A. M.
    Coiro, J.
    Zacharchuk, C.
    Ewesuedo, R.
    CANCER RESEARCH, 2017, 77
  • [8] Postgraduate Assessment Approaches Across Surgical Specialties: A Systematic Review of the Published Evidence
    Hanrahan, John Gerrard
    Sideris, Michail
    Pasha, Terouz
    Dedeilia, Aikaterini
    Papalois, Apostolos
    Papalois, Vassilios
    ACADEMIC MEDICINE, 2021, 96 (02) : 285 - 295
  • [9] Prophylactic and therapeutic benefits of a monoclonal antibody against the fusion protein of human metapneumovirus in a mouse model
    Hamelin, Marie-Eve
    Gagnon, Constance
    Prince, Gregory A.
    Kiener, Peter
    Suzich, Joann
    Ulbrandt, Nancy
    Boivin, Guy
    ANTIVIRAL RESEARCH, 2010, 88 (01) : 31 - 37
  • [10] Biosimilars: a systematic review of published and ongoing clinical trials of antipsoriatics in chronic inflammatory diseases
    Nast, Alexander
    Rosumeck, Stefanie
    Seidenschnur, Karin
    JOURNAL DER DEUTSCHEN DERMATOLOGISCHEN GESELLSCHAFT, 2015, 13 (04): : 294 - 301
12345